Physician profile
Jaadeep Mann
NPI 1013538248
$1,169.56
in general payments reported to CMS, 2019-2025
12 companies · $396 in 2025
The $396 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $48.62 · 2021: $314 · 2022: $21.30 · 2023: $63.76 · 2024: $326 · 2025: $396.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $785.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $785.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $202.37 | 2022-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $194.25 | 2023-2024 | Xarelto |
| Abbvie INC. | $184.80 | 2024-2025 | |
| Vapotherm INC | $150.00 | 2021 | |
| Aurinia Pharma U.S., INC. | $104.74 | 2021 | |
| Merck Sharp & Dohme LLC | $91.31 | 2023-2025 | Dificid, Zerbaxa |
| Novo Nordisk INC | $63.28 | 2024-2025 | Wegovy |
| Novartis Pharmaceuticals Corporation | $61.01 | 2020-2021 | |
| Astrazeneca Pharmaceuticals LP | $55.66 | 2020-2025 | |
| Fisher & Paykel Healthcare INC | $26.41 | 2024 | Fisher & Paykel Healthcare |
| Ethicon US, LLC | $19.59 | 2021 | |
| Gilead Sciences, INC. | $16.14 | 2024 | Veklury |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jaadeep Mann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.